These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3963856

  • 1. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
    Onoyama Y, Nakajima T, Tanaka M.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
    [Abstract] [Full Text] [Related]

  • 2. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 3. Optimization of cancer radiotherapy with selective sensitizers.
    Wideröe R.
    Strahlenther Onkol; 1987 Jun; 163(6):378-84. PubMed ID: 3603365
    [Abstract] [Full Text] [Related]

  • 4. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K, Sasai K, Shibamoto Y, Tsutsui K, Fushiki M, Nishidai T, Takahashi M, Abe M.
    Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
    [Abstract] [Full Text] [Related]

  • 5. [Radiosensitization research in cancer therapy].
    Sugahara T.
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
    Schreiber A, Krause M, Zips D, Dörfler A, Richter K, Vettermann S, Petersen C, Beuthien-Baumann B, Thümmler D, Baumann M.
    Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
    [Abstract] [Full Text] [Related]

  • 12. Radiosensitizers: rationale and potential.
    Brown JM.
    Cancer Treat Rep; 1981 Jun; 65 Suppl 2():95-102. PubMed ID: 7346152
    [Abstract] [Full Text] [Related]

  • 13. Chemical radiosensitizers for use in radiotherapy.
    Wardman P.
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [Abstract] [Full Text] [Related]

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Aug; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

  • 15. [Developments in the experimental methods of evaluating hypoxic cell sensitizers].
    Shibamoto Y, Sasai K, Takahashi M, Abe M.
    Gan No Rinsho; 1988 Oct; 34(13):1859-63. PubMed ID: 3199519
    [Abstract] [Full Text] [Related]

  • 16. Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial.
    Haffty BG, Hurley R, Peters LJ.
    Cancer J Sci Am; 1999 Oct; 5(6):341-7. PubMed ID: 10606475
    [Abstract] [Full Text] [Related]

  • 17. [Radiosensitizing effects of perfluorochemicals].
    Hasegawa T, Harima K, Tanaka Y.
    Gan No Rinsho; 1988 Oct; 34(13):1864-8. PubMed ID: 3143842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interaction between electron-affinic sensitizers.
    McNally JN, de Ronde J.
    Br J Cancer Suppl; 1978 Jun; 3():90-4. PubMed ID: 277264
    [Abstract] [Full Text] [Related]

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.